Vaccine Weekly articles from November 2001

Vaccine Weekly archives from November 2001

Early Cytotoxic T-Cell Responses May Be Key To Development.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Vaccines for HIV should harness the powerful cytotoxic T-lymphocyte (CTL) responses to the virus seen in the acute stages of infection, researchers in Wisconsin...

Study Will Try Smaller Vaccine Dose.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers are beginning a large new study to see if they can dilute the nation's small stockpile of smallpox vaccine to make it stretch farther in case of a bioterrorist attack. Fresh batches of...

New DNA-Based Vaccine Approach Protects Mice.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers at Ohio State University have shown that mice injected with fragments of DNA from anthrax bacteria can be immunized against the disease. In traditional vaccine approaches, researchers...

Clinical Trials Begin In Healthy Individuals At UC Davis.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- A clinical trial testing the safety and tolerability of two investigational AIDS vaccines for healthy individuals is being launched at the University of California Davis School of Medicine and Medical...

Tumor Vaccine Causes Regression, Reduces Metastasis In Incurable Melanoma.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using a new vaccine consisting of autologous tumor cells complexed with a hapten, investigators at Thomas Jefferson University's Kimmel Cancer Center have seen...

Hepatitis B Vaccine Response Falls Short In Youth, Those With HIV.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Older adolescents may not be fully protected after being vaccinated against hepatitis B virus. Furthermore, youth who are infected with human...

BioPort Is Trying To Get FDA Approval For Manufacturing Vaccine.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- The nation's only manufacturer of an anthrax vaccine planned to submit new documents to the federal government, trying to gain approval to distribute the vaccine. Lansing, Michigan-based BioPort...

Phase II Study Of Humanized Anti-IL-4 Antibody Initiated.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Protein Design Labs, Inc. (PDL) announced the start of a Phase II clinical trial to evaluate its humanized antibody to interleukin-4 (IL-4) in asthma. The randomized, double-blind,...

Avant Licenses Vaccine Technology To U.S. Department of Defense Contractor.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics Inc. has signed a license agreement with DynPort Vaccine Co. LLC (DVC) for exclusive rights to use certain components of Avant's vaccine technology. Financial terms of the...

Public Health Executive Explores Making Vaccines Available To Public.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- The executive director of the American Public Health Association, Mohammad N. Akhter, MD, MPH, has told a Senate committee that a national group of experts should be formed immediately to study the...

FDA Fast Tracks Antigenics' Oncophage For Kidney Cancer.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration has designated Oncophage, a cancer vaccine candidate developed by Antigenics, Inc. (AGEN), a Fast Track Product for the treatment of renal cell carcinoma. In...

Genetically Engineered Vaccine Elicits Immune Response To Kill Tumor.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- A genetically engineered vaccine appears to direct the immune system to kill tumors caused by human papillomavirus 16 (HPV-16), report researchers from the University of Pennsylvania and Johns Hopkins...

TherImmune Awarded $4.5 Million For HIV Vaccine Development Services.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- TherImmune Research Corp. has been awarded a three-year $4.5 million HIV Vaccine Development Task Order from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) Indefinite Delivery -...

Avax Expects Clearance To Continue With Its Autologous Cell Vaccines.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc. has submitted its response to the U.S. Food and Drug Administration's (FDA) request for additional information related to the clinical hold of Avax's clinical trials of M-Vax and...

Antex To Continue DOD Grant Work On Gastrointestinal Vaccine.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Antex Biologics, Inc. has announced it completed work funded by a U.S. Army Small Business Innovation Research (SBIR) grant on the development of an oral microbead vaccine to protect U.S. troops against...

Viragen Reports On Avian Transgenic Project.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Viragen, Inc. and Roslin Institute (Scotland) jointly reported on the progress of the Avian Transgenic Project. Using the same antibody construct previously expressed in chicken cell lines, Viragen...

Amarillo Biosciences Receives Grant To Develop H. pylori Vaccine.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Amarillo Biosciences, Inc. has received a Small Business Innovative Research (SBIR) grant from the U.S. National Institutes of Health (NIH) for $96,248 to be used to develop a vaccine to combat...

Phase II Trial Results Of Therapeutic Vaccine Are Encouraging.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Xenova Group plc (XNVA), had announced results from the Phase II clinical efficacy trial conducted in collaboration with its partner, GlaxoSmithKline (GSK), with TA-HSV, a therapeutic vaccine designed...

Cambridge Antibody Technology Announces Product Development Alliance With Merck.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology has entered into a collaboration and license agreement with Merck & Co. Inc. for the research and development of products specific for a key target involved in disease...

Elispot Assay May Hasten Development Of African Vaccine.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Enzyme-linked immunospot (Elispot) analysis of immune responses to HIV is aiding the development of a vaccine targeting viral strains common in Africa,...

Immunoglobulins From Resistant Sex Workers May Provide Protection.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - HIV specific immunoglobulin from persistently uninfected sex workers may aid in the development of an HIV vaccine effective against a wide range of viral...

Healthy People Urged To Postpone Immunization Until November.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- New recommendations for influenza vaccination issued by the U.S. Centers for Disease Control and Prevention (CDC) are now in effect, urging health care providers to prioritize vaccination of the elderly...

Alemtuzumab Successful In Clinical Trial.(Brief Article)
November 7, 2001... 2001 NOV 7 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany (SHR), announced that Campath (alemtuzumab), a humanized monoclonal antibody, was successfully tested in a clinical trial for the treatment of T-PLL (T-cell prolymphocytic...

Intermediate Viral Structures May Be Target.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Viral structures formed during HIV coreceptor interactions can be targeted by potential HIV vaccines, researchers in the United States report. "Human...

Study: Men C Vaccine Is Safe For Infants.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- A Men C vaccine, introduced into the United Kingdom immunization schedule two years ago is safe, with minimal side effects, reports a study in the Archives of Disease in Childhood. Concerns were...

Complementary DNAs Detected In Breast Tumors Possess Vaccine Potential.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Researchers at a major cancer center in Buffalo, New York, have identified a transcription factor that has potential for developing a breast cancer vaccine....

Gag Optimization Improves Immunogenicity.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Germany have improved the effectiveness of an HIV vaccine based on viral genetic material. "We have analyzed the influence of codon usage...

Flu Shots Important For People With Asthma.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Influenza can exacerbate asthma in children and adults, and now is the time for the nation's 17 million people with asthma to protect themselves with flu shots. The American Academy of Allergy,...

Salmonella Germ May Hold Key To Effective Vaccine.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- The Salmonella germ that causes common food poisoning may hold the key to developing a vaccine that could eradicate typhoid fever, researchers say. Typhoid vaccines already exist but could be made...

CRR7 Ligands Heighten Gene Vaccine Effectiveness.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - U.S. researchers have determined two important chemokines can increase the effectiveness of vaccines containing DNA and other genetic material. ...

Yale Researchers Develop First Vaccine, Test In Animal Model.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Yale scientists have successfully immunized mice against West Nile virus, raising the possibility of developing a vaccine for humans against the potentially fatal, mosquito-borne infection. ...

VaxGen Awarded Second NIH Grant To Develop AIDS Vaccine.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- VaxGen Inc. has been awarded the second part of a $1.1 million grant from the National Institutes of Health (NIH) to continue the development of a vaccine designed to prevent infection by HIV subtype...

NIH Uses Bioject's Needle-Free Injection System For DNA AIDS Vaccine Study.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- The Biojector 2000 (B-2000) has been chosen by the Dale and Betty Bumpers Vaccine Research Center (VRC) as the delivery device for its first AIDS vaccine in human clinical testing. The B-2000 was...

PowderJect Awarded $1 Million Grant For Development Of HIV DNA Vaccine.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- PowderJect Pharmaceuticals Plc (PJP), a specialty vaccines company, and its wholly owned subsidiary PowderJect Vaccines Inc., have, in association with the University of Pittsburgh, been awarded $1...

CDC Seeks Access To Vaccine Currently Reserved For Military Personnel.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Federal health officials are lining up access to the military's anthrax vaccine in case it's needed for a civilian who is allergic to antibiotics and thus needs some other protection after exposure to...

Avant Licenses Vaccine Technology to U.S. Department of Defense Contractor.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics Inc. (AVAN) has signed a license agreement with DynPort Vaccine Company LLC ("DVC") for exclusive rights to use certain components of Avant's vaccine technology. Financial...

Bio-Terrorism.Info Database and Weekly Report Launch Powered by NewsRx Artificial Intelligence Technology.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- NewsRx has leveraged its technology platform to create Bio-Terrorism.Info, a new database and weekly report. NewsRx is the leading provider of life science databases and daily and weekly health news....

Lymphoma Patients Sought For Customized Therapy Trial.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Patients with low-grade B-cell non-Hodgkin lymphoma who have received no prior therapy are being recruited by 22 of the top cancer research sites across the United States and Canada. These sites are...

Colorectal Cancer Patients Participate In Clinical Trial.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- An investigational vaccine for the treatment of colorectal cancer, one of the most common and deadly forms of cancer, has been cleared by the U.S. Food and Drug Administration (FDA) for clinical trial....

Aastrom Biosciences Gets CE Mark For Dendritic Cell Therapy Product.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences Inc. has obtained approval to affix the CE Mark to the DC-I Cell Therapy Kit for the ex vivo production of human dendritic cells, allowing the company to market and sell the product...

VaxGen To Manufacture AIDS Vaccine In South Korea.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- VaxGen Inc. (VXGN) and the city of Incheon, South Korea, have signed an agreement that provides VaxGen land on which to construct a facility to manufacture the company's AIDS vaccine. This agreement...

Aastrom Biosciences Reports First Quarter Results.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences Inc., a firm that develops proprietary cell therapeutic technologies, has announced financial results for the first fiscal quarter ended September 30, 2001. For the quarter, the...

Chiron Reports Third Quarter Earnings Boost Of 30 Cents Per Share.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) reported pro forma income from continuing operations of $58 million, or $0.30 per share, for the third quarter of 2001, as compared with $43 million, or $0.23 per share, reported...

Crucell Announces 300% Jump In Third Quarter Revenues.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell saw its third quarter revenues increase by 300% compared with the same quarter last year. Contributing to third quarter results is a deal with Johnson &...

PowderJect Opposes Vical Inc.'s Core DNA Vaccines Patent.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- PowderJect Pharmaceuticals Plc (PJP), a specialty vaccines company, and its wholly owned subsidiary PowderJect Vaccines, Inc., have successfully challenged Vical Inc.'s (VICL) core European patent...

Maxygen Awarded $3.7 Million USAID Grant For Vaccine Research.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Maxygen Inc. has received a $3.7 million, three-year grant from the U.S. Agency for International Development (USAID) to support the research and development of a novel, broadly protective malaria...

Vaccine Fund Will Allow Research With Prime-Boost Technology.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- The director of the Malaria Vaccine Initiative has announced a two-year, $1.5 million partnership for research and testing of a malaria vaccine. Dr. Regina Rabinovich said the Maryland-based...

Genzyme Molecular Oncology Patents Newly Discovered Immunogens.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology (GZMO) has been issued a U.S. patent for the discovery of novel synthetic peptides and pharmaceutical compositions useful as therapeutic melanoma vaccines. Discovered by...

Oregovomab Produced Favorable Clinical Trial Results.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (ALXFF) announced favorable early results from a concurrent OvaRex/second-line chemotherapy clinical trial in relapsed ovarian cancer where prognosis is extraordinarily poor, and where...

Cell Genesys Initiates Phase II Trial Of GVAX Vaccine.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Approximately 60 patients with pancreatic cancer will be enrolled in a new Phase II clinical trial of Cell Genesys Inc.'s GVAX vaccine. The study is being conducted at the Johns Hopkins Oncology...

Whooping Cough Booster Vaccine To Be Given To Preschool Children.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- The United Kingdom government is to introduce a preschool booster vaccination against pertussis (commonly known as whooping cough) from November 5, 2001, to reduce further illness and death from...

Biomira Initiates Phase II Pilot Study Of BLP25 Vaccine.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Biomira Inc. (BIOM, BRA) has initiated of a Phase II clinical trial evaluating BLP25 vaccine in patients with prostate cancer. The study is designed to test active specific immunotherapy with...

Dendreon, Gambro Collaborate On U.S. Cell Collection Network.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Gambro AB (GAMBa,GAMBb), an international medical technology and health care company, is teaming up with Dendreon Corp. (DNDN) to support the commercialization of Dendreon's therapeutic vaccines....

Oncophage Gets FDA Fast Track Designation.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has designated Oncophage, Antigenics Inc.'s personalized cancer vaccine, a fast track product for the treatment of renal cell carcinoma. Under the FDA...

HuMax-IL15 Potent Against Inflammation.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Genmab A/S has announced that HuMax-IL15, a human monoclonal antibody targeting the cytokine interleukin (IL)-15, demonstrated potent activity in arresting inflammation in preclinical studies. ...

Drug Companies Respond On Smallpox Vaccine.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Ten drug companies have responded to a government call for information on how the nation's vaccine makers could produce about 250 million doses of smallpox vaccine by the end of next year, federal...

UK Firm Spearheads Manufacture Of Modern Vaccine.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- U.S. health authorities have turned to a little-known British company to speed development of its first batch of modern vaccines for smallpox, a fatal virus far more infectious than anthrax. ...

IDM Secures Supply Of Biopharmaceutical Delivery Bags For Cancer Vaccines.(Brief Article)
November 14, 2001... 2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Immuno-Designed Molecules, S.A. (IDM), has signed a worldwide agreement with STEDIM, a leading manufacturer of sterile, single-use container systems for the biopharmaceutical and the biotech...

Viral Protein Alterations Have Similar Impact On HIV, SHIV Specific Antibodies.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in New York City have presented evidence in favor of the controversial use of simian/human immunodeficiency virus (SHIV)-based models for HIV...

Irradiated Tumor Cells Activate Immune Response After Vaccination.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using bioengineering techniques, medical researchers at the University of Kansas have constructed a tumor vaccine that might help patients with melanoma. ...

Cellular Factors Expand Grass Allergen Vaccine Effectiveness.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Vectors encoded with the genes for two cytokines will increase allergen immunotherapy effectiveness. The two cytokines, interferon (IFN)-gamma and...

Panel Suggests Federally Supervised Vaccine Labs.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- The government should supervise development and production of vaccines against germs that might be used in bioterror attacks, a congressionally created panel told the Bush administration. The...

New Technique Helps Immune System Detect, Fight Cancer.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- A new therapeutic technique helps the immune system identify and attack abnormal cells, according to Howard M. Grey, MD, a leading expert in immunotherapy for cancer. "It was once thought that...

Drug Shown To Slow Growth Of Tumors In Mice.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- A new experimental drug has been found to slow the growth of prostate cancer tumors in laboratory studies conducted at Cedars-Sinai Medical Center. The findings, presented at the AACR-NCI-EORTC...

Pentavalent Vaccine As Effective As Individual Vaccines In Pediatric Study.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Investigators at the University of California - Los Angeles (UCLA) Center for Vaccine Research have established that a new combination vaccine produced by...

Transformed Bacteria Produce HCV-Specific Immune Response In Mice.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - U.S. National Institutes of Health (NIH) researchers report they have transformed Salmonella bacteria so that it elicits an immune response against hepatitis C...

New Details About Epitope Targeted By Potent Monoclonal Antibody.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and Europe say that they have shed new light on a potential HIV vaccine target. In a multi-institutional study, Carol E....

BioPort May Resume Vaccine Production By End Of November.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- A Michigan company that has failed to meet federal standards should be producing more anthrax vaccine by the end of November, federal officials said. Still, they added, there are no plans to offer...

Vaccine Manufacturer Reaches Milestone In Licensing Process With FDA.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- BioPort Corp. has reached a milestone in its licensing process with the U.S. Food and Drug Administration (FDA) by shipping required documentation for its manufacturing facility renovations to the FDA....

Biogen Announces New Senior Vice President, International.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Biogen (BGEN) has announced several new appointments in its international commercial organization. Robert A. Hamm has been named senior vice president-international, replacing Mark Leuchtenberger,...

Plexus Vaccine, Inc., Appoints Scientific Advisory Board.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Plexus Vaccine, Inc., San Diego, California, has selected six experts to serve on its Scientific Advisory Board. Supporting Dr. Robert Deans, Plexus Vaccine's vice president of Research and...

Washington, DC, Veterans Center Tests For Anthrax.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- A mail room in the Veterans Affairs Medical Center, Washington, DC, tested positive for trace amounts of anthrax. Authorities were set to order the release of powerful chemicals in a Senate office...

Cyclacel Receives Patent On Drug Target Of Cancer Cell Cycle.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Cyclacel, Ltd., has been granted United States Patent 6,242,201 covering the cancer drug target PCNA (proliferating cell nuclear antigen). Cyclacel's CYC102 program is seeking to prevent cancer...

ImClone, Bristol-Myers Squibb Seek FDA Approval Of Erbitux.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- ImClone Systems, Inc., (IMCL) and Bristol-Myers Squibb Co. (BMY) have completed their rolling Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA) for approval...

Human Trial Underway Utilizing CEA/TRICOM Vaccine.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Therion Biologics Corp.'s CEA/TRICOM vaccine was noted at the AACR-NCI-EORTC International Conference as a next generation therapeutic for improved treatment of tumors found in a majority of colorectal...

Article Describes New "Golden Age" Of Antiviral Drugs And Vaccines.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Advances in the study of viral genomes has laid the foundation for rapid progress in the development of new antiviral vaccines and drugs. "The 1950s were the golden age of antibiotics to treat...

Aastrom Biosciences Reports First Quarter Results.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) has announced financial results for the first fiscal quarter ended September 30, 2001. For the quarter, the company raised approximately $7 million from the sale of...

Biomira Solidifies Cash Position As Phase III Trials Begin.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) reported financial for the nine months ended September 30, 2001, reflect a consolidated net loss from operations of $30.0 million or $0.59 per share compared with $33.4 million or...

Genecor Reports Flat Revenues, Decreased Earnings In 3rd Quarter.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Genencor International, Inc., (GCOR) has reported flat revenues and a dip in earnings for the third quarter. The company said that, for the quarter ended September 30, 2001, product revenues were...

Therion Completes $36.5 Million Private Financing For Development.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Providing new resources to advance the company's clinical development programs, Therion Biologics has closed a $36.5 million private financing with leading venture investors. Therion will use the...

Researchers Target Liver Cells By Nonviral Compacted DNA Complexes.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Copernicus Therapeutics, Inc., researchers have found that the size and shape of compacted DNA particles markedly influences the efficiency of targeted gene transfer to liver cells. As reported in...

Vaccine Successful In Phase IIa Clinical Trials.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Xenova Group plc (XNVA) announced the successful results of clinical trials for two of its vaccines for the treatment of human papillomavirus (HPV)-associated diseases. HPV infection is a...

Shire Biologics Contracts With Canadian Government To Prevent Pandemic.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Shire Biologics, part of Shire Pharmaceuticals Group PLC (SHP.L, SHQ), has signed a 10-year contract with the government of Canada to assure a state of readiness in the case of an influenza pandemic...

Shire Biologics Signs Distribution Pack With Baxter Corp.(Brief Article)
November 21, 2001... 2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Shire Biologics, Laval, Quebec, has signed an agreement with Baxter Corp., Deerfield, Illinois, for the distribution in Canada of a new meningococcal group C vaccine, currently commercialized in...